The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.

The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...

In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...

Global communications giant Tata and local pharmaceutical distributor Medpharm are now eyeing entering into a lease with the ...

Nvidia has been the hottest stock since the start of the AI revolution, and I see one particular healthcare business ...

The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...

Students who graduate from the innovation center at the Reinhardt Road high school will earn associate’s degrees — equal to ...

Elisabeth Rosenthal Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat […] ...

Safaricom explains its role in the new health insurance programme, to support the Ministry of Health through the Integrated ...

The other highlight of the Modi-Biden meeting was India’s accession to the Clean Economy and Fair Economy agreements of the ...

I have questions about whether groundnut oil is safe. Yes, it is. It is heart-friendly. However, you should make sure that it ...